Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Olmesartan franchise

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Olmesartan franchise was produced by Daiichi Sankyo.

Amgen strikes $240m autoimmune deal with Evoq Therapeutics

Amgen strikes $240m autoimmune deal with Evoq Therapeutics

Amgen’s autoimmune franchise includes psoriasis blockbuster Otezla (apremilast), which it picked up from Celgene after it merged with Bristol Myers Squibb in 2019.

New dosing option for AZ’s Imfinzi approved in the EU and UK

New dosing option for AZ’s Imfinzi approved in the EU and UK In AZ’s recent third quarter results, the British drugmaker reported that its oncology franchise had grown by 24% to $8.15bn – with Imfinzi accounting for $1.48bn of that amount.

Merck wins speedy FDA review for 15-valent pneumococcal vaccine

Merck wins speedy FDA review for 15-valent pneumococcal vaccine If approved, Merck’s V114 will be a close competitor of Pfizer's Prevnar-13, although Pfizer is seeking to defend its franchise with its new generation 20-valent pneumococcal vaccine.

Novartis receives FDA breakthrough therapy designation for rare disease med

Novartis receives FDA breakthrough therapy designation for rare disease med Alexion’s other long-acting C5 inhibitor, Ultomiris (ravulizumab‑cwvz) is also approved in these indications, making the franchise Novartis potential main competitors.

CONNECT Customer Engagement Framework

Through delivery of the programme throughout Europe (and now beyond), CONNECT has been able to harmonise, for the first time at Sanofi Genzyme, the customer-facing approach across brands, franchises, countries

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Iguazu

Iguazu Ltd is a digital healthcare agency, delivering tactical and innovative solutions. WHAT WE DO We are Closed Loop Marketing...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics